Steve Cutler

9 results

Dublin-headquartered clinical trials company Icon, which employs more than 1,000 people in Ireland, has said it expects revenues of between $2.73 bill(...)

Ciarán Murray, chairman and former CEO of Icon. Photograph: Dara Mac Dónaill

Icon may not be a household name in Ireland but it’s a global powerhouse in the pharmaceuticals sector, with operations in 37 countries. And all of it(...)

Icon  employs more than 12,000 staff worldwide, including more than 1,000 in Dublin and Limerick

Dublin-based and Nasdaq-listed clinical trials group Icon has reported a record $605 million in new business for the third quarter. Reported income f(...)

Icon headquarters in Sandyford, Dublin

Revenue at Dublin-headquartered clinical trials company Icon, which employs more than 1,000 people in the Republic, increased 7.1 per cent during the (...)

Icon’s headquarters at Leopardstown in Dublin: the company is a global provider of drug development solutions and services

Clinical trials group Icon, which employs more than 1,000 people in the Republic, recorded a tax expense of $7.4 million (€5.93 million) during the fo(...)

Icon headquarters at Leopardstown, Dublin.

Revenue at clinical trials group Icon, which employs more than 1,000 people in Ireland, is projected to rise by of 7-10 per cent this year, the compan(...)

Icon: net income in the quarter increased by 13.4 per cent to $71.4 million

Dublin-headquartered drugs group Icon, which employs more than 1,000 people in Ireland, reported a record number of business wins in the third quarter(...)

Incoming Icon chief executive Dr Steve Cutler was appointed to the company’s board in November 2015.

Clinical trials group Icon has appointed chief operating officer Steve Cutler as chief executive. Dr Cutler will succeed Ciaran Murray, who will becom(...)

Profit follows move by Wall Street firms to embrace cost-cutting measures after trading revenue declined in four of the past five years. Photograph: Reuters.

JP Morgan Chase, the biggest US bank by assets, said second-quarter profit climbed 5.2 per cent as expenses fell. Net income advanced to $6.29 billio(...)